Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STroke

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University

About this trial

It is uncertain whether intravenous methylprednisolone improves outcomes for acute anterior circulation large vessel occlusion (LVO) patients with a large infarct core. In this study, the investigators hypothesize that methylprednisolone plus endovascular thrombectomy (EVT) might be superior to EVT alone in patients with evidence of a large infarct volume. The primary objective of the study is to establish the efficacy of methylprednisolone with EVT in patients with acute anterior circulation LVO and a large infarct core.

Eligibility criteria

Qualifiers

Aged 18 to 85 years;

Clinically diagnosed acute ischemic stroke with screening NIHSS ≥6;

Time from last known well to randomization ≤24 hours;

Pre-stroke mRS score of 0-1;

Disqualifiers

Intracranial hemorrhage on NCCT or MRI;

Allergy to corticosteroids;

Allergy to contrast agents;

Severe infectious disease unsuitable for corticosteroid therapy or concurrent contraindications to corticosteroid treatment;

Trial design

Treatments tested in this trial

  • Methylprednisolone sodium succinate
  • Placebo

Treatment groups

912 Participants
are divided into 2 treatment groups